ReviewRSC medicinal chemistry2026

Development landscape of ketohexokinase-C (KHK-C) inhibitors for fructose-driven metabolic disorders: from hit discovery to clinical trials.

Sri Venkata Gopal Ainapurapu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.